Newly Diagnosed?
We Can Help Getting the correct diagnosis and the most appropriate treatment from the start is crucial 
|
|
|
The management of gestational trophoblastic disease (GTD) -- particularly when it is advanced -- is a highly specialized area within the field of gynecology. The fact that the disease is so rare means that few physicians have had experience treating such patients. Therefore it is important to be treated by doctors who have extensive clinical expertise in this rare form of cancer.
A Team Approach to Care
Memorial Sloan-Kettering has a multidisciplinary team approach to providing the best possible treatment for women with gestational trophoblastic disease. Our gynecologic surgeons, medical oncologists, radiation oncologists, and radiologists work together to treat GTD. In addition, these doctors and other healthcare professionals work to provide a full range of supportive care, including counseling for women who have concerns regarding their diagnosis.
For women whose disease has spread, or metastasized, to other parts of the body, the gynecologic cancer team coordinates treatment with other Memorial Sloan-Kettering experts to provide the best care possible.
Through our own research programs and those of the Gynecologic Oncology Group (a multi-institutional clinical research group supported by the National Cancer Institute), we are committed to conducting clinical trials that will improve the survival and quality of life for women with GTD.
Treating GTD
At Memorial Sloan-Kettering, we have one of the most sophisticated programs for the diagnosis and management of women with high-risk GTD. We offer treatment regimens that are designed to deliver the most effective chemotherapy using a combination of drugs, with the goal being to cure the disease. When necessary, we also use surgery and radiation therapy in combination with chemotherapy.
Through careful monitoring and with the appropriate treatment, even women with advanced gestational trophoblastic disease have a survival rate of more than 90 percent.
